(30 days)
Not Found
No
The device description and intended use are purely mechanical and do not mention any software, algorithms, or data processing capabilities that would suggest AI/ML.
Yes
The device is described as treating stable and unstable proximal fractures of the humerus, which falls under the definition of a therapeutic device as it directly addresses and aims to alleviate a medical condition.
No
The device description indicates that the AOS Proximal Humeral Nail is a titanium intramedullary nail used to treat humerus fractures. This describes a surgical implant used for treatment, not a device used to diagnose a medical condition.
No
The device description clearly states it is a titanium intramedullary nail with associated hardware (screws, end cap), indicating it is a physical implant, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for treating bone fractures (proximal humerus fractures). This is a surgical implant used in vivo (within the body) to stabilize bone.
- Device Description: The description details a physical implant (intramedullary nail, screws, end cap) made of titanium, designed to be inserted into the humerus.
- Lack of IVD Characteristics: An IVD is a medical device used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. This device does not perform any such tests.
Therefore, based on the provided information, the AOS Proximal Humeral Nail is a surgical implant, not an IVD.
N/A
Intended Use / Indications for Use
The AOS Proximal Humeral Nail is intended to treat stable and unstable proximal fractures of the humerus including two and three, and in some cases, four part humerus fractures.
Product codes (comma separated list FDA assigned to the subject device)
HSB
Device Description
The AOS Proximal Humeral Nail is a titanium humeral intramedullary nail that is designed to enter the humerus through the greater tuberosity. It consists of an intramedullary nail. proximal and distal locking screws, and an end cap.
The AOS Proximal Humeral Nail is a cannulated nail with a 6° proximal bend and a proximal diameter of 10mm. The Humeral Nail is produced in a 15cm length with a distal diameter of 8mm. The proximal end of the nail has six holes which accept the 5.0mm cancellous screw. The distal end of the nail contains four cross locking holes which are designed to accept a 3.5mm cortical screw. The proximal end of the nail is threaded to accept an end cap.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
humerus
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
mechanical testing showed that the device is substantially equivalent.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3020 Intramedullary fixation rod.
(a)
Identification. An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.(b)
Classification. Class II.
0
K090478(jpg 1/1)
MAR 2 6 2009
510(k) SUMMARY
| NAME OF FIRM: | Advanced Orthopaedic Solutions, Inc.
386 Beech Ave., Unit B6
Torrance, CA 90501
310.533.9966
FAX 310.533.9876 |
|-------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
| 510(k) CONTACT PERSON: | Paul Doner, Vice President Operations |
| TRADE NAME: | AOS Proximal Humeral Nail |
| COMMON NAME: | Intramedullary Fixation Rod |
| CLASSIFICATION: | 888.3020 Intramedullary Fixation Rod |
| DEVICE CODE: | HSB |
| SUBSTANTIALLY
EQUIVALENT DEVICE: | AOS Humeral Nail (K050241, Cleared March 14, 2005) |
INTENDED USE:
The AOS Proximal Humeral Nail is intended to treat stable and unstable proximal fractures of the humerus including two and three, and in some cases, four part humerus fractures.
DEVICE DESCRIPTION AND SUBSTANTIAL EQUIVALENCE RATIONALES:
The AOS Proximal Humeral Nail is a titanium humeral intramedullary nail that is designed to enter the humerus through the greater tuberosity. It consists of an intramedullary nail. proximal and distal locking screws, and an end cap.
The AOS Proximal Humeral Nail is a cannulated nail with a 6° proximal bend and a proximal diameter of 10mm. The Humeral Nail is produced in a 15cm length with a distal diameter of 8mm. The proximal end of the nail has six holes which accept the 5.0mm cancellous screw. The distal end of the nail contains four cross locking holes which are designed to accept a 3.5mm cortical screw. The proximal end of the nail is threaded to accept an end cap.
The AOS Proximal Humeral Nail was shown to be substantially equivalent to the AOS Humeral Nail. The AOS Proximal Humeral Nail was shown to be substantially equivalent in design, materials and intended use to the device listed below. Once assembled the geometry of the AOS nail and the predicate devices are virtually identical. Additionally, mechanical testing showed that the device is substantially equivalent.
AOS Humeral Nail
K050241, Cleared March 14, 2005
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, facing to the right. The eagle is rendered in black. Surrounding the eagle is a circular border containing the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a sans-serif font. The text is also in black.
Public Health Service
MAR 2 6 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Advanced Orthopaedics Solutions, Inc. % Mr. Paul Doner 386 Beech Avenue, Unit B6 · Torrance, California 90501
Re: K090478
Trade/Device Name: AOS Proximal Humeral Nail Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary Fixation Rod Regulatory Class: II Product Code: HSB Dated: February 19, 2009 Received: February 24, 2009
Dear Mr. Doner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Mr. Paul Doner
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours. elkerson
Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number (if known): Kogo478 (ps (ps 1/1)
Device Name: AOS Humeral Nail
Indications for Use:
The AOS Humeral Nail is intended to treat stable and unstable proximal fractures of the humerus including two and three, and in some cases, four part humerus fractures.
Prescription Use: X (Part 21 CFR 801 Subpart D) and /or
Over the Counter Use: (Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Concurrence of CDRH, Office of Device Evaluation (ODE)
P.A. Thangmy
(Divisio) Division of General, Restorative, and Neurological Devices
51030 N - K090478
CONFIDENTIAL
Special 510(k) - AOS Humeral Nail